McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
45,000
Employees45,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
45,000
Employees45,000

MCK Key Statistics

Market cap
101.61B
Market cap101.61B
Price-Earnings ratio
25.59
Price-Earnings ratio25.59
Dividend yield
0.37%
Dividend yield0.37%
Average volume
580.01K
Average volume580.01K
High today
$824.12
High today$824.12
Low today
$807.00
Low today$807.00
Open price
$819.26
Open price$819.26
Volume
324.69K
Volume324.69K
52 Week high
$895.58
52 Week high$895.58
52 Week low
$570.51
52 Week low$570.51

Stock Snapshot

The current McKesson(MCK) stock price is $823.26, with a market capitalization of 101.61B. The stock trades at a price-to-earnings (P/E) ratio of 25.59 and offers a dividend yield of 37.2%.

As of 2026-01-21, McKesson(MCK) stock has fluctuated between $807.00 and $824.12. The current price stands at $823.26, placing the stock +2.0% above today's low and -0.1% off the high.

The McKesson(MCK)'s current trading volume is 324.69K, compared to an average daily volume of 580.01K.

In the last year, McKesson(MCK) shares hit a 52-week high of $895.58 and a 52-week low of $570.51.

In the last year, McKesson(MCK) shares hit a 52-week high of $895.58 and a 52-week low of $570.51.

MCK News

Simply Wall St 10h
Does McKesson’s Expanded Oncology Data Role Quietly Reshape Its Long-Term Healthcare Moat?

In January 2026, AOP Health US announced broader U.S. distribution of its critical care beta-blocker Rapiblyk through McKesson, Cardinal, Cencora Specialty Dist...

Does McKesson’s Expanded Oncology Data Role Quietly Reshape Its Long-Term Healthcare Moat?
TipRanks 1d
McKesson: Expanding Biosimilar and Oncology Platform Drives Incremental Upside and Supports Buy Rating

Analyst Allen Lutz of Bank of America Securities maintained a Buy rating on McKesson, retaining the price target of $950.00. Claim 50% Off TipRanks Premium Unlo...

Simply Wall St 6d
McKesson Valuation Check As Rapiblyk Distribution Expands In US Critical Cardiac Care

AOP Health US has expanded U.S. distribution of Rapiblyk (landiolol) through several wholesalers, including McKesson (MCK). This expansion gives hospitals wider...

McKesson Valuation Check As Rapiblyk Distribution Expands In US Critical Cardiac Care

Analyst ratings

80%

of 20 ratings
Buy
80%
Hold
15%
Sell
5%

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.